These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 16793744)

  • 1. Lorenzo's oil and platelet activation in adrenomyeloneuropathy and asymptomatic X-linked adrenoleukodystrophy.
    Konijnenberg A; van Geel BM; Sturk A; Schaap MC; von dem Borne AE; de Bruijne-Admiraal LG; Schutgens RB; Assies J; Barth PG
    Platelets; 1998; 9(1):41-8. PubMed ID: 16793744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of Lorenzo's oil on oxidative stress in X-linked adrenoleukodystrophy.
    Deon M; Wajner M; Sirtori LR; Fitarelli D; Coelho DM; Sitta A; Barschak AG; Ferreira GC; Haeser A; Giugliani R; Vargas CR
    J Neurol Sci; 2006 Sep; 247(2):157-64. PubMed ID: 16750542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy of X-linked adrenoleukodystrophy.
    Semmler A; Köhler W; Jung HH; Weller M; Linnebank M
    Expert Rev Neurother; 2008 Sep; 8(9):1367-79. PubMed ID: 18759549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A two-year trial of oleic and erucic acids ("Lorenzo's oil") as treatment for adrenomyeloneuropathy.
    Aubourg P; Adamsbaum C; Lavallard-Rousseau MC; Rocchiccioli F; Cartier N; Jambaqué I; Jakobezak C; Lemaitre A; Boureau F; Wolf C
    N Engl J Med; 1993 Sep; 329(11):745-52. PubMed ID: 8350883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression of abnormalities in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy despite treatment with "Lorenzo's oil".
    van Geel BM; Assies J; Haverkort EB; Koelman JH; Verbeeten B; Wanders RJ; Barth PG
    J Neurol Neurosurg Psychiatry; 1999 Sep; 67(3):290-9. PubMed ID: 10449548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elongation of very long-chain fatty acids is enhanced in X-linked adrenoleukodystrophy.
    Kemp S; Valianpour F; Denis S; Ofman R; Sanders RJ; Mooyer P; Barth PG; Wanders RJ
    Mol Genet Metab; 2005 Feb; 84(2):144-51. PubMed ID: 15670720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [X-linked adrenoleukodystrophy--2 case reports].
    Dumić M; Ille J; Plavsić V; Filipović-Grcić B; Vrljicak K; Barisić N; Roscher A
    Lijec Vjesn; 1998; 120(1-2):19-23. PubMed ID: 9650481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follow-up of 89 asymptomatic patients with adrenoleukodystrophy treated with Lorenzo's oil.
    Moser HW; Raymond GV; Lu SE; Muenz LR; Moser AB; Xu J; Jones RO; Loes DJ; Melhem ER; Dubey P; Bezman L; Brereton NH; Odone A
    Arch Neurol; 2005 Jul; 62(7):1073-80. PubMed ID: 16009761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Very long chain fatty acids in X-linked adrenoleukodystrophy brain after treatment with Lorenzo's oil.
    Poulos A; Gibson R; Sharp P; Beckman K; Grattan-Smith P
    Ann Neurol; 1994 Nov; 36(5):741-6. PubMed ID: 7979219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is subclinical adrenal failure in adrenoleukodystrophy/adrenomyeloneuropathy reversible?
    Cappa M; Bizzarri C; Giannone G; Aiello C; Di Biase A
    J Endocrinol Invest; 2011 Nov; 34(10):753-6. PubMed ID: 21399389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Backache as the initial symptom of adrenomyeloneuropathy].
    Benito-León J; Zamorano T; Martín-Peña G; Tapia MA; Alvarez-Linera J
    Rev Neurol; 2000 Dec 16-31; 31(12):1167-70. PubMed ID: 11205553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hexacosanoic and docosanoic acids plasma levels in patients with cerebral childhood and asymptomatic X-linked adrenoleukodystrophy: Lorenzo's oil effect.
    Deon M; Garcia MP; Sitta A; Barschak AG; Coelho DM; Schimit GO; Pigatto M; Jardim LB; Wajner M; Giugliani R; Vargas CR
    Metab Brain Dis; 2008 Mar; 23(1):43-9. PubMed ID: 18026827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of erucic acid on platelets in patients with adrenoleukodystrophy.
    Kickler TS; Zinkham WH; Moser A; Shankroff J; Borel J; Moser H
    Biochem Mol Med; 1996 Apr; 57(2):125-33. PubMed ID: 8733890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early oxidative damage underlying neurodegeneration in X-adrenoleukodystrophy.
    Fourcade S; López-Erauskin J; Galino J; Duval C; Naudi A; Jove M; Kemp S; Villarroya F; Ferrer I; Pamplona R; Portero-Otin M; Pujol A
    Hum Mol Genet; 2008 Jun; 17(12):1762-73. PubMed ID: 18344354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased platelet membrane anisotropy in patients with adrenoleukodystrophy treated with erucic acid (22:1)-rich triglycerides.
    Stöckler S; Opper C; Greinacher A; Hunneman DH; Korenke GC; Unkrig CJ; Hanefeld F
    J Inherit Metab Dis; 1997 Mar; 20(1):54-8. PubMed ID: 9061568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cystathionine beta-synthase variant c.844_845ins68 protects against CNS demyelination in X-linked adrenoleukodystrophy.
    Linnebank M; Semmler A; Kleijer WJ; van der Sterre ML; Gärtner J; Fliessbach K; Sokolowski P; Köhler W; Schlegel U; Klockgether T; Wanders RJ; Schmidt S; Wüllner U; Kemp S
    Hum Mutat; 2006 Oct; 27(10):1063-4. PubMed ID: 16941496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Endocrine disease in adrenoleukodystrophy].
    Girard S; Bruckert E; Turpin G
    Ann Med Interne (Paris); 2001 Feb; 152(1):15-26. PubMed ID: 11240421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diet therapy in the treatment of neuropediatric disorders].
    Chaves-Carballo E
    Rev Neurol; 2003 Aug 1-15; 37(3):267-74. PubMed ID: 12938059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lovastatin therapy for X-linked adrenoleukodystrophy: clinical and biochemical observations on 12 patients.
    Pai GS; Khan M; Barbosa E; Key LL; Craver JR; Curé JK; Betros R; Singh I
    Mol Genet Metab; 2000 Apr; 69(4):312-22. PubMed ID: 10870849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predominance of the adrenomyeloneuropathy phenotype of X-linked adrenoleukodystrophy in The Netherlands: a survey of 30 kindreds.
    van Geel BM; Assies J; Weverling GJ; Barth PG
    Neurology; 1994 Dec; 44(12):2343-6. PubMed ID: 7991123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.